DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,119 | -38.1% | 1,093 | -40.1% | 0.00% | -50.0% |
| Q2 2023 | $437,924 | -4.8% | 1,825 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $459,865 | -5.0% | 1,825 | +0.1% | 0.00% | -20.0% |
| Q4 2022 | $484,254 | +8.3% | 1,824 | +5.4% | 0.01% | 0.0% |
| Q3 2022 | $447,000 | +1.8% | 1,730 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $439,000 | -14.8% | 1,730 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $515,000 | -31.1% | 1,756 | -22.7% | 0.00% | -33.3% |
| Q4 2021 | $747,000 | +1.1% | 2,271 | -6.4% | 0.01% | 0.0% |
| Q3 2021 | $739,000 | +13.5% | 2,427 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $651,000 | +23.8% | 2,427 | +3.9% | 0.01% | 0.0% |
| Q1 2021 | $526,000 | -0.9% | 2,336 | -2.3% | 0.01% | 0.0% |
| Q4 2020 | $531,000 | +11.3% | 2,390 | +7.9% | 0.01% | 0.0% |
| Q3 2020 | $477,000 | +17.2% | 2,215 | -3.7% | 0.01% | 0.0% |
| Q2 2020 | $407,000 | +84.2% | 2,300 | +43.8% | 0.01% | +66.7% |
| Q1 2020 | $221,000 | -19.3% | 1,600 | -10.4% | 0.00% | 0.0% |
| Q4 2019 | $274,000 | +6.2% | 1,785 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $258,000 | +4.9% | 1,785 | +3.9% | 0.00% | 0.0% |
| Q2 2019 | $246,000 | -6.5% | 1,718 | -13.7% | 0.00% | 0.0% |
| Q1 2019 | $263,000 | +28.3% | 1,990 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $205,000 | -5.1% | 1,990 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $216,000 | +5.4% | 1,990 | -24.5% | 0.00% | -25.0% |
| Q4 2016 | $205,000 | -10.9% | 2,636 | +15.8% | 0.00% | -20.0% |
| Q2 2016 | $230,000 | -3.4% | 2,277 | -9.2% | 0.01% | -16.7% |
| Q1 2016 | $238,000 | +0.8% | 2,507 | -1.2% | 0.01% | 0.0% |
| Q4 2015 | $236,000 | +10.3% | 2,537 | +1.2% | 0.01% | 0.0% |
| Q3 2015 | $214,000 | -4.5% | 2,507 | -4.2% | 0.01% | 0.0% |
| Q2 2015 | $224,000 | -8.2% | 2,616 | -9.0% | 0.01% | 0.0% |
| Q1 2015 | $244,000 | -17.6% | 2,874 | -16.7% | 0.01% | -25.0% |
| Q4 2014 | $296,000 | -13.5% | 3,449 | -23.4% | 0.01% | -11.1% |
| Q3 2014 | $342,000 | -92.4% | 4,502 | -92.1% | 0.01% | -92.2% |
| Q2 2014 | $4,511,000 | +2.0% | 57,292 | -2.8% | 0.12% | +3.6% |
| Q1 2014 | $4,422,000 | -1.2% | 58,956 | +1.7% | 0.11% | -5.1% |
| Q4 2013 | $4,477,000 | +14.4% | 57,993 | +2.7% | 0.12% | +6.4% |
| Q3 2013 | $3,915,000 | +9.3% | 56,482 | -0.2% | 0.11% | +3.8% |
| Q2 2013 | $3,581,000 | – | 56,573 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |